HOUSE 2071117th CongressReferred to the Subcommittee on Health.
Medicare Prescription Drug Price Negotiation Act of 2021
- Last Action
- 3/19/2021
Actions
- 2021-03-19Referred to the Subcommittee on Health.
- 2021-03-18Referred to the Subcommittee on Health.
- 2021-03-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-03-18Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-03-18Introduced in House
- 2021-03-18Introduced in House
CRS Summary
As of 2021-03-18 (00)
Medicare Prescription Drug Price Negotiation Act of 2021
This bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits the CMS from doing so.
Cosponsors (12)
- Mark Pocan (D-WI)
- Kathy Castor (D-FL)
- Raúl Grijalva (D-AZ)
- Stephen Lynch (D-MA)
- Ruben Gallego (D-AZ)
- Debbie Wasserman Schultz (D-FL)
- David Cicilline (D-RI)
- Chellie Pingree (D-ME)
- Raul Ruiz (D-CA)
- BETTY MCCOLLUM (D-MN)
- CAROLYN MALONEY (D-NY)
- ADAM SMITH (D-WA)
Subjects
- Health care costs and insurance
- Inflation and prices
- Medicare
- Prescription drugs
- Public contracts and procurement
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.